News | November 25, 2023
Laurus Labs acquires 87.59% stake in Laurus Bio Private
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Acquisition underscores Merck’s ongoing commitment to developing treatments for neurodegenerative diseases
Total transaction value of the divestment is Rs. 3,660 million
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Investment is additive to KKR’s existing health care growth strategy
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Clinical Trial Data Services supports small to midsize sponsor companies helping them to take the next step towards market approval for their drug or device product.
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
Subscribe To Our Newsletter & Stay Updated
